USE OF BAYES PROBABILITY Sample Clauses

USE OF BAYES PROBABILITY. Generalised Bayes Probability Function: p  x = 1 exp[− 1  x−Μx T Σ−1 x−Μx  ]  2 Π d ∣Σ∣ 1 2
Sample 1
AutoNDA by SimpleDocs

Related to USE OF BAYES PROBABILITY

  • Pricing Information Provided Orally by Underwriters Firm Shares: [—] Price per share: $[—] The Underwriters have an option to purchase up to [—] Option Shares AUSPEX PHARMACEUTICALS, INC. 0000 Xxxxx Xxxxxx Xxxxx Court, Suite 400 La Jolla, CA 92037 X. X. XXXXXX SECURITIES LLC 000 Xxxxxxx Xxxxxx Xxx Xxxx, XX 00000 Ladies and Gentlemen: The undersigned refers to the proposed Underwriting Agreement (the “Underwriting Agreement”) between Auspex Pharmaceuticals, Inc., a Delaware corporation (the “Company”) and the several underwriters named therein (the “Underwriters”), for whom X. X. Xxxxxx Securities LLC (the “Representative”) is acting as representative. As an inducement to the Representative to execute the Underwriting Agreement on behalf of the Underwriters in connection with the proposed public offering of shares of the Company’s common stock, par value $0.0001 per share (the “Common Stock”), pursuant to a Registration Statement on Form S-1, the undersigned hereby agrees that from the date hereof and until 60 days after the public offering date set forth on the final prospectus used to sell the Common Stock (the “Public Offering Date”) pursuant to the Underwriting Agreement (such period being referred to herein as the “Lock-Up Period”), the undersigned will not (and will cause any spouse, domestic partner or immediate family member of the spouse, domestic partner or the undersigned living in the undersigned’s household, any partnership, corporation, limited liability company or other entity within the undersigned’s control, and any trustee of any trust that holds Common Stock or other securities of the Company for the benefit of the undersigned or such spouse, domestic partner or immediate family member not to) offer, sell, contract to sell (including any short sale), pledge, hypothecate, establish an open “put equivalent position” within the meaning of Rule 16a-1(h) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), grant any option, right or warrant for the sale of, purchase any option or contract to sell, sell any option or contract to purchase, or otherwise encumber, dispose of or transfer, or grant any rights with respect to, directly or indirectly, any shares of Common Stock or securities convertible into or exchangeable or exercisable for any shares of Common Stock (including without limitation, Common Stock or such other securities which may be deemed to be beneficially owned by the undersigned in accordance with the rules and regulations of the Securities and Exchange Commission and securities which may be issued upon exercise of a stock option or warrant), enter into a transaction which would have the same effect, or enter into any swap, hedge or other arrangement that transfers, in whole or in part, any of the economic consequences of ownership of the Common Stock, whether any such aforementioned transaction is to be settled by delivery of the Common Stock or such other securities, in cash or otherwise, or publicly disclose the

  • Independence from Material Breach Determination Except as set forth in Section X.D.1.c, these provisions for payment of Stipulated Penalties shall not affect or otherwise set a standard for OIG’s decision that Xxxxx has materially breached this IA, which decision shall be made at OIG’s discretion and shall be governed by the provisions in Section X.D, below.

  • How Do I Get More Information? This Notice summarizes the Action, the terms of the Settlements, and your rights and options in connection with the Settlements. More details are in the Settlement Agreements, which are available for your review at xxx.XxxxxxxxxXxxXxxxxxxxxXxxxxxxxxx.xxx. The Settlement Website also has the Second Amended Complaint and other documents relating to the Settlements. You may also call toll-free 0-000-000-0000 or write the Claims Administrator at: Financial Aid Antitrust Settlements, c/o Claims Administrator, 0000 Xxxx Xxxxxx, Xxxxx 0000, Xxxxxxxxxxxx, XX 00000. To: Settlement Class Member Email Address From: Claims Administrator Subject: Notice of Proposed Class Action Settlement – Xxxxx, et al. x. Xxxxx University, et al. Please visit xxx.XxxxxxxxxXxxXxxxxxxxxXxxxxxxxxx.xxx for more information. • The Court has preliminarily approved proposed settlements (“Settlements”) with the following ten schools: Brown University, the University of Chicago, the Trustees of Columbia University in the City of New York, Trustees of Dartmouth College, Duke University, Emory University, Northwestern University, Xxxxxxx Xxxxx Xxxx University, Vanderbilt University, and Yale University (collectively the “Settling Universities”). • The Court has also preliminarily approved a class of students who attended one or more of the Settling Universities during certain time periods. This is referred to as the “Settlement Class,” which is defined in more detail below.

  • Exclusion de garanties A. Si vous êtes un client qui est un consommateur (quelqu’un qui utilise le Logiciel tvOS en dehors son commerce, entreprise ou profession), il se peut que vous bénéficiez, dans votre pays de résidence, de droits selon lesquels les limitations suivantes ne s’appliqueraient pas à vous. Dans les pays où ces limitations sont interdites, elles ne s’appliquent pas à vous. Pour en savoir plus sur vos droits, prenez contact avec un organisme local de conseil aux consommateurs. B. VOUS RECONNAISSEZ ET ACCEPTEZ EXPRESSÉMENT QUE, DANS LA MESURE PERMISE PAR LA LÉGISLATION APPLICABLE, L’UTILISATION DU LOGICIEL tvOS ET DE TOUT SERVICE FOURNI OU ACCESSIBLE PAR LEDIT LOGICIEL tvOS EST À VOS RISQUES ET PÉRILS ET QUE VOUS ASSUMEZ L’INTÉGRALITÉ DES RISQUES RELATIFS À LA QUALITÉ, AUX PERFORMANCES, À L’EXACTITUDE ET AUX EFFORTS. C. DANS LES LIMITES MAXIMALES AUTORISÉES PAR LA LÉGISLATION EN VIGUEUR, LE LOGICIEL tvOS ET LES SERVICES SONT FOURNIS « TELS QUELS » AVEC TOUS LEURS DÉFAUTS ET SANS AUCUNE GARANTIE D’AUCUNE SORTE. tvOS ET LES CONCÉDANTS D’APPLE (DÉSIGNÉS COLLECTIVEMENT PAR L’EXPRESSION « APPLE » AUX FINS DES DISPOSITIONS DES PARAGRAPHES 7 ET 8) EXCLUENT PAR LA PRÉSENTE LICENCE LA TOTALITÉ DES GARANTIES ET CONDITIONS, EXPLICITES, TACITES OU LÉGALES, Y COMPRIS DE FAÇON NON LIMITATIVE LES GARANTIES ET/OU CONDITIONS IMPLICITES DE QUALITÉ MARCHANDE, DE QUALITÉ SATISFAISANTE, D’ADÉQUATION À UN OBJECTIF PARTICULIER, D’EXACTITUDE, DE SÉRÉNITÉ D’UTILISATION ET DE NON EMPIÉTEMENT SUR LES DROITS DE TIERCES PARTIES, LE TOUT À L’ÉGARD DU LOGICIEL tvOS ET DES SERVICES. D. APPLE NE GARANTIT NULLEMENT L’ABSENCE DE TROUBLES LORS DE VOTRE UTILISATION DU LOGICIEL tvOS ET DES SERVICES, QUE LES FONCTIONS CONTENUES DANS LE LOGICIEL tvOS OU LES SERVICES EXÉCUTÉS OU FOURNIS PAR CELUI-CI CORRESPONDRONT À VOS BESOINS, QUE LE FONCTIONNEMENT DU LOGICIEL tvOS OU DES SERVICES SERA ININTERROMPU OU EXEMPT D’ERREUR, QUE TOUS LES SERVICES SERONT TOUJOURS DISPONIBLES, QUE TOUT DÉFAUT DU LOGICIEL tvOS OU DES SERVICES SERA CORRIGÉ OU QUE LE LOGICIEL tvOS SERA COMPATIBLE AVEC TOUT AUTRE LOGICIEL, APPLICATION OU SERVICE TIERS. L’INSTALLATION DU LOGICIEL tvOS PEUT AFFECTER LA DISPONIBILITÉ ET L’UTILISATION DE LOGICIELS, APPLICATIONS OU SERVICES XX XXXXXX PARTIE, AINSI QUE DE PRODUITS ET SERVICES APPLE. E. VOUS RECONNAISSEZ ÉGALEMENT QUE LE LOGICIEL tvOS ET LES SERVICES NE SONT NI DESTINÉS NI ADAPTÉS À UN USAGE DANS DES SITUATIONS OU DES ENVIRONNEMENTS OÙ UNE DÉFAILLANCE, DES ERREURS OU DES INEXACTITUDES DU CONTENU, DES DONNÉES OU DES INFORMATIONS FOURNIS PAR LE LOGICIEL tvOS OU LES SERVICES RISQUENT D’ENTRAÎNER DES BLESSURES, DES ACCIDENTS XXXXXX OU MORTELS POUR LES PERSONNES OU DES DOMMAGES PHYSIQUES OU ENVIRONNEMENTAUX. CES SITUATIONS COMPRENNENT NOTAMMENT LE FONCTIONNEMENT D’INSTALLATIONS NUCLÉAIRES, LA NAVIGATION OU LES SYSTÈMES DE COMMUNICATION AÉRIENS, LE CONTRÔLE AÉRIEN, LES SYSTÈMES D’ENTRETIEN ARTIFICIEL DE LA VIE OU LES SYSTÈMES D’ARMEMENT.

  • Presentation of Potential Target Businesses The Company shall cause each of the Initial Shareholders to agree that, in order to minimize potential conflicts of interest which may arise from multiple affiliations, the Initial Shareholders will present to the Company for its consideration, prior to presentation to any other person or company, any suitable opportunity to acquire an operating business, until the earlier of the consummation by the Company of a Business Combination or the liquidation of the Company, subject to any pre-existing fiduciary obligations the Initial Shareholders might have.

  • Reasonable Suspicion a. Reasonable suspicion to test a Covered Employees for illegal drugs or alcohol will exist when specific, reliable objective facts and circumstances would create a good faith belief in a prudent person that the employee has used a drug or alcohol. Such circumstances include, but are not limited to, the employee’s behavior or appearance while on any SFMTA jobsite, while on SFMTA business or in SFMTA facilities, and recognized and accepted symptoms of intoxication or impairment caused by drugs or alcohol, that are not reasonably explained by other causes such as fatigue, lack of sleep, proper use of prescription drugs, or reaction to noxious fumes or smoke. b. Any individual or employee can report an employee who may be under the influence of alcohol or drugs. Upon receiving a report of possible alcohol or illegal drugs on the job, two (2) trained employer representatives will verify and document the basis for the suspicion and request testing. The first employer representative shall verify and document the employee’s appearance and behavior based on the above-stated indicators and, if appropriate, recommend testing to the second employer representative. At work locations within the border of the City and County of San Francisco (including San Francisco International Airport), the second employer representative shall verify and document the appearance and behavior of the employee based on the above-stated indicators and has final authority to require the employee to be tested. At work locations outside the border of the City and County of San Francisco, the second employer representative shall confer with the first employer representative to verify the employee’s behavior based on the above-stated indicators, and the second employer representative has the final authority to require the employee to be tested. In the event only one trained employer representative is available onsite, the representative shall confer with any other trained employer representative within the City to verify the employee’s behavior. The second trained employer representative shall have the final authority to require the employee to be tested. c. If the SFMTA requires an employee to be tested under reasonable suspicion, then the employee may ask for representation. Representation may include, but is not limited to, union representatives and shop stewards. If the employee requests representation, the SFMTA may allow a reasonable amount (a maximum of one hour) of time for the employee to obtain representation. Such request shall not delay the administration of the tests for more than one hour from the time the employee is notified that the employee will be tested. d. Moreover, if the SFMTA has reasonable suspicion or suspect that a prescription medication may have interfered with or may have had a direct impact on an employee’s job performance, it may require that employee to be tested. e. The department representative(s) shall be required to accurately document and file the incident and the employee shall be required to complete a consent form prior to any testing. If an employee refuses to Submit to testing, then the SFMTA shall treat the refusal as having tested positive and shall immediately take appropriate disciplinary action pursuant to the attached discipline matrix. f. The SFMTA shall bear the costs for any required testing for alcohol and/or drugs under this section. Any counseling and rehabilitation services shall be on the employee’s time and at the employee’s cost, except that employees may use accrued paid time off to attend treatment and may utilize any resources covered by insurance. Employees shall have the right to use any accrued but unused leave balances while enrolled in any counseling or rehabilitation program. Any request by an employee to re-test a specimen shall be at the employee’s cost.

  • Voluntariness and Consequences of Consent Denial or Withdrawal The Participant’s participation in the Plan and the Participant’s grant of consent is purely voluntary. The Participant may deny or withdraw his or her consent at any time. If the Participant does not consent, or if the Participant withdraws his or her consent, the Participant cannot participate in the Plan. This would not affect the Participant’s salary as an employee or his or her career; the Participant would merely forfeit the opportunities associated with the Plan.

  • No Unauthorized Use or Disclosure Executive agrees that he will not, at any time during or after Executive’s employment by Company, make any unauthorized disclosure of, and will prevent the removal from Company premises of, Confidential Information or Work Product of Company (or its affiliates), or make any use thereof, except in the carrying out of Executive’s responsibilities during the course of Executive’s employment with Company. Executive shall use commercially reasonable efforts to cause all persons or entities to whom any Confidential Information shall be disclosed by him hereunder to observe the terms and conditions set forth herein as though each such person or entity was bound hereby. Executive shall have no obligation hereunder to keep confidential any Confidential Information if and to the extent disclosure thereof is specifically required by law; provided, however, that in the event disclosure is required by applicable law, Executive shall provide Company with prompt notice of such requirement prior to making any such disclosure, so that Company may seek an appropriate protective order. At the request of Company at any time, Executive agrees to deliver to Company all Confidential Information that he may possess or control. Executive agrees that all Confidential Information of Company (whether now or hereafter existing) conceived, discovered or made by him during the period of Executive’s employment by Company exclusively belongs to Company (and not to Executive), and Executive will promptly disclose such Confidential Information to Company and perform all actions reasonably requested by Company to establish and confirm such exclusive ownership. Affiliates of Company shall be third party beneficiaries of Executive’s obligations under this Article 6. As a result of Executive’s employment by Company, Executive may also from time to time have access to, or knowledge of, Confidential Information or Work Product of third parties, such as customers, suppliers, partners, joint venturers, and the like, of Company and its affiliates. Executive also agrees to preserve and protect the confidentiality of such third party Confidential Information and Work Product to the same extent, and on the same basis, as Company’s Confidential Information and Work Product.

  • Reasonable Suspicion Testing All Employees Performing Safety-Sensitive Functions A. Reasonable suspicion testing for alcohol or controlled substances may be directed by the Employer for any employee performing safety-sensitive functions when there is reason to suspect that alcohol or controlled substance use may be adversely affecting the employee’s job performance or that the employee may present a danger to the physical safety of the employee or another. B. Specific objective grounds must be stated in writing that support the reasonable suspicion. Examples of specific objective grounds include but are not limited to: 1. Physical symptoms consistent with alcohol and/or controlled substance use; 2. Evidence or observation of alcohol or controlled substance use, possession, sale, or delivery; or 3. The occurrence of an accident(s) where a trained manager, supervisor or lead worker suspects alcohol or other controlled substance use may have been a factor.

  • Exceptional Access to Thick Registration Data In case of a registrar failure, deaccreditation, court order, etc. that prompts the temporary or definitive transfer of its domain names to another registrar, at the request of ICANN, Registry Operator will provide ICANN with up-­‐to-­‐date data for the domain names of the losing registrar. The data will be provided in the format specified in Specification 2 for Data Escrow. The file will only contain data related to the domain names of the losing registrar. Registry Operator will provide the data as soon as commercially practicable, but in no event later than five (5) calendar days following ICANN’s request. Unless otherwise agreed by Registry Operator and ICANN, the file will be made available for download by ICANN in the same manner as the data specified in Section 3.1 of this Specification.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!